Abstract
This study aimed to investigate the effect of canagliflozin (CAN) or metformin (MET) on investigated biochemical parameters in obese diabetic rat model. Obesity induced by melted butter administration and hyperlipidemic rats were subjected to streptozotocin (STZ; 35 mg/kg i.p) to develop the diabetic model (D). Animals were grouped as control (C), D none treated and diabetic treated with CAN (10 mg/kg) or MET (100 mg/kg) for two and four weeks. Both treated groups showed significant reduction in body weight and CAN group exhibited significant decrease in oral glucose tolerance test (OGTT) as compared to D or MET group in the experimental periods. Both drugs showed hypolipidemic activity by reducing total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) and elevating high-density lipoprotein (HDL) as compared to D group values in the two intervals with advantage in MET effect. Both treatments achieved significant reduction in the diabetic elevated serum values for liver and kidney functions. These results indicate that butter high-fat diet and low dose of STZ makes normal male adult rat associated with hyperlipidemia, glucose intolerance and disturbed liver and kidney functions. Treatment by either CAN or MET resisted the metabolism disturbance of the butter high fat diet/STZ -induced obese type 2 diabetes mellitus rats. Key words: Canagliflozin, metformin, obese diabetic rats, glucose intolerance, biochemical parameters.
Highlights
Data from the World Health Organization (WHO) shows that overweight and obesity prevalence has increased dramatically throughout recent decades accompanied by increased rates of type II diabetes (T2DM) in the Middle Eastern/North African region
The body weight significant increment was expected due to the imbalance in energy homeostasis developed in high-fat diet (HFD) fed rats, which is consistent with previous studies demonstrating that fat accumulation is greater when more energy comes from dietary fat than from carbohydrate or protein (Woods et al, 2003)
PGC-1β expression greatly increased in cultured rat primary hepatocytes treated with individual saturated fatty acid (SFA), after incubation with palmitic acid
Summary
Data from the World Health Organization (WHO) shows that overweight and obesity prevalence has increased dramatically throughout recent decades accompanied by increased rates of type II diabetes (T2DM) in the Middle Eastern/North African region. This is greatest in the Arabian Gulf area characterized by significant changes in socioeconomic status and lifestyle. The International Diabetes Federation (IDF, 2011) statistics for T2DM showed six Arabic-speaking countries, Kuwait, Lebanon, Qatar, Saudi Arabia, Bahrain, and United Arab Emirates among the world’s leaders in terms of T2DM prevalence. The prevalence rates among adults showed the highest in Kuwait (Badran and Laher, 2012).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
